Vanguard Group’s Adicet Bio ACET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2M Buy
3,272,522
+66,640
+2% +$40.7K ﹤0.01% 3533
2025
Q1
$2.42M Hold
3,205,882
﹤0.01% 3429
2024
Q4
$3.08M Hold
3,205,882
﹤0.01% 3438
2024
Q3
$4.62M Buy
3,205,882
+105,926
+3% +$153K ﹤0.01% 3299
2024
Q2
$3.75M Sell
3,099,956
-26,622
-0.9% -$32.2K ﹤0.01% 3373
2024
Q1
$7.35M Buy
3,126,578
+1,441,503
+86% +$3.39M ﹤0.01% 3131
2023
Q4
$3.18M Buy
1,685,075
+12,689
+0.8% +$24K ﹤0.01% 3443
2023
Q3
$2.29M Buy
1,672,386
+3,700
+0.2% +$5.07K ﹤0.01% 3531
2023
Q2
$4.05M Sell
1,668,686
-21,783
-1% -$52.9K ﹤0.01% 3402
2023
Q1
$9.74M Sell
1,690,469
-623
-0% -$3.59K ﹤0.01% 2948
2022
Q4
$15.1M Buy
1,691,092
+191,833
+13% +$1.71M ﹤0.01% 2762
2022
Q3
$21.3M Buy
1,499,259
+264,049
+21% +$3.75M ﹤0.01% 2593
2022
Q2
$18M Buy
1,235,210
+163,555
+15% +$2.39M ﹤0.01% 2687
2022
Q1
$21.4M Sell
1,071,655
-175,478
-14% -$3.5M ﹤0.01% 2735
2021
Q4
$21.8M Buy
1,247,133
+180,314
+17% +$3.15M ﹤0.01% 2792
2021
Q3
$8.36M Buy
1,066,819
+5,998
+0.6% +$47K ﹤0.01% 3356
2021
Q2
$10.9M Buy
1,060,821
+252,833
+31% +$2.6M ﹤0.01% 3156
2021
Q1
$10.6M Buy
807,988
+443,847
+122% +$5.81M ﹤0.01% 3109
2020
Q4
$5.12M Buy
364,141
+270,333
+288% +$3.8M ﹤0.01% 3344
2020
Q3
$1.12M Sell
93,808
-8,897
-9% -$106K ﹤0.01% 3635
2020
Q2
$1.55M Sell
102,705
-4,916
-5% -$74K ﹤0.01% 3507
2020
Q1
$776K Sell
107,621
-3,726
-3% -$26.9K ﹤0.01% 3560
2019
Q4
$1.16M Sell
111,347
-454
-0.4% -$4.74K ﹤0.01% 3601
2019
Q3
$6.92M Buy
111,801
+14,339
+15% +$887K ﹤0.01% 3012
2019
Q2
$6.96M Buy
97,462
+19,943
+26% +$1.42M ﹤0.01% 3052
2019
Q1
$3.7M Buy
77,519
+35,080
+83% +$1.67M ﹤0.01% 3250
2018
Q4
$2.56M Buy
42,439
+1,226
+3% +$74K ﹤0.01% 3297
2018
Q3
$4.37M Buy
41,213
+1,078
+3% +$114K ﹤0.01% 3284
2018
Q2
$2.57M Buy
40,135
+6,291
+19% +$403K ﹤0.01% 3421
2018
Q1
$2.27M Buy
+33,844
New +$2.27M ﹤0.01% 3415